J. Prichard, Delilah D Coconubo, M. Gero, B. Noorbehesht, Michelle B Azimov
{"title":"Acquired C1-Esterase Inhibitor Deficiency Associated with Burkitt Lymphoma","authors":"J. Prichard, Delilah D Coconubo, M. Gero, B. Noorbehesht, Michelle B Azimov","doi":"10.30654/mjia.10008","DOIUrl":null,"url":null,"abstract":"C1-esterase inhibitor deficiency results in recurrent episodes of angioedema. Acquired deficiency has been associated with B-cell lymphoproliferative disorders, rheumatologic diseases or, in a small proportion of patients, the cause remains unknown. Of the malignancies associated with acquired C1-esterase deficiency, indolent lymphomas and plasma cell disorders are the most common. Aggressive lymphomas are rarely reported in such cases. We report the association of Burkitt lymphoma, a highly aggressive B-cell malignancy, which evolved seven months after the initial symptoms of acquired angioedema in a fifty-five year old man. Following treatment of the lymphoma, episodes of angioedema ceased. An association of acquired angioedema with Burkitt lymphoma has not previously been reported.","PeriodicalId":413658,"journal":{"name":"Mathews Journal of Immunology & Allergy","volume":"78 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mathews Journal of Immunology & Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30654/mjia.10008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
C1-esterase inhibitor deficiency results in recurrent episodes of angioedema. Acquired deficiency has been associated with B-cell lymphoproliferative disorders, rheumatologic diseases or, in a small proportion of patients, the cause remains unknown. Of the malignancies associated with acquired C1-esterase deficiency, indolent lymphomas and plasma cell disorders are the most common. Aggressive lymphomas are rarely reported in such cases. We report the association of Burkitt lymphoma, a highly aggressive B-cell malignancy, which evolved seven months after the initial symptoms of acquired angioedema in a fifty-five year old man. Following treatment of the lymphoma, episodes of angioedema ceased. An association of acquired angioedema with Burkitt lymphoma has not previously been reported.